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MTT assay. Expression of mRNA for chemokines and cytokines 
was analyzed by ribonuclease protection assay and expresion of 
mRNA for metaloprotease (MMP-1), by RT-PCR. NO production 
was evaluated by the Greiss Method and PGE2, IL-8 and IL-6 by 
ELISA. 
Results: Firstly, when we examined the individual effect of mito- 
chondrial inhibitors, we observed that antimycin A and oligomycin 
decrease cell viability in a dose- and time-dependent manner 
(at 48 h, antimycin A: 524-7 and oligomycin: 424-5 vs basal 
100%, n=6, p<0.01). However, the rest of MRC inhibitors (I, II, 
and IV) did not modified the viability. Secondly, we explored the 
chemokines and cytokines mRNA and we found that only an- 
timycin A and oligomycin induced in a dose-dependent manner 
the mRNA of chemokines IL-8 and MCP-1. Other chemokines 
such as, Rantes, 1-309, and IP-10 were not modified. Thereafter, 
we examined whether the rise in IL-8 mRNA in cultured chon- 
drocytes was accompanied by the synthesis of IL-8 protein and 
we found that it was induced by antimycin A and oligomycin (at 
24 h; basal, 624-14; antimycin A, 1354-34, oligomycin, 3254-12 
pg/ml/50.000 cells, n=4). In relation to cytokines evaluated we 
found that again, only antimycin A and oligomycin induced in a 
dose-dependent manner the mRNA of cytokines IL-6, IL-1 b; and 
IL-18. Other cytokines such as, IL-12, IL-10, IL-lb; orthe IL-1Ra 
were not significantly modified. The rest of inhibitors did not mod- 
ified the mRNA expression studied. Thereafther we determined 
that the rise in IL-6 mRNA in cultured chondrocytes was accom- 
panied by the synthesis of IL-6 protein (at 24 h; basal, 404-12; 
antimycin A, 1804-44, oligomycin, 4254-12 pg/ml/50.000 cells, 
n=4). When MMP-1 was examined, it was found that oligomycin 
increases significantly its expression in a dose-dependent man- 
ner.Thirdly, when we assesed NO and PGE2 production we found 
that neither inhibitor employed were able to modulate NO synthe- 
sis. However, in relation to PGE2, we described as antimycin A 
and oligomycin increase significantly PGE2 after 48 h of stim- 
ulation (basal, 1054-15; antimycin A, 8254-34 and oligomycin, 
11124-325 pg/ml/50.000 cells). 
Conclusion: These results show that mitochondrial dysfunction 
could modulate inflammatory response in human OA chondro- 
cytes and that inhibition of complex III and V could be especially 
relevant in relation to inflammatory response. These data could 
be important for a better understanding of the role of mitochon- 
dria in the pathogenesis of cartilage degradation. 
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Initial disorder in OA is the metabolic abnormalities of chondro- 
cyte characterized by secretion of proteinases, suppression of 
of matrix synthesis, and apoptosis of chondrocyte. It has been 
reported that OA is associated with underlying abnormalities in 
bone structure and mineralization. Analysis of Framingham study 
indicated that low serum levels of vitamin D appears to be as- 
sociated with an increased risk for progression of the knee OA. 
Association of early knee OA with a polymorphism of the vitamin 
D receptor gene is also shown. Objective of this study is to de- 
termine the effect of 1,25(OH)2D3 on chondrocyte cell death and 
the expression of apoptosis-related molecules in STR/ort mice, 
naturally developing OA model. 
Materials and Methods: Thirty nine male STR/ort mice were 
studied by randomly assigning them to two treatment groups 
in study of six months duration. 1,25(OH)2D3 (0.11~g/kg body 
weight)were administrated subcutaneously from 8 weeks of age 
and sacrificed 25 or 35 weeks of age. Toluidine blue stain- 
ing, TUNEL assay, and immunohistochemistry against apoptosis- 
related molecules including iNOS, TNF-~, TRAIL, caspase-3, 
FAS, DR-5 were performed on serial paraffin sections of the knee 
joint from mice. 
Results: Histological examination showed STR/ort mice exhib- 
ited OA lesions of knee joint at 35 weeks after birth, however 
no changes at 25 weeks. These OA lesions were suppressed 
in mice treated with 1,25(OH)2D3. TUNEL positive chondrocytes 
were observed frequently in control mice at 35 weeks after birth. 
1,25(OH)2D3 treatment decreased the number of TUNEL posi- 
tive chondrocytes. Immunohistological examination indicated that 
chondrocytes expressed iNOS, TNF-~, TRAIL, caspase-3, and 
FAS DR-5 at 35 weeks. 1,25(OH)2D3 treatment decreased num- 
ber of chondrocytes which were positive for these apoptosis- 
related molecules. Among these molecules, iNOS expression 
was suppressed most significantly with 1,25(OH)2D3 treatment. 
Discussion: In STR/ort mice, chondrocyte cell death is shown 
to be correlated with the progression of OA. Chondrocyte apop- 
tosis is induced with several molecules in vivo and in vitro. 
Present study indicated that 1,25(OH)2D3 suppressed chondro- 
cyte cell death. Administration of 1,25(OH)2D3 also significantly 
suppressed iNOS expression of chondrocyte. We suppose that 
inhibition of chondrocyte cell death may be the one of the path- 
way for the anti-OA effect of 1,25(OH)2D3 observed in this mice. 
Above results suggest 1,25(OH)2D3 may have therapeutic value 
for OA. 
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Purpose: Targeted remodeling of aged bone for repair of micro 
cracks is essential for maintenance of bone quality. How osteo- 
clasts target old bone in order to sustain the quality of the skele- 
ton by constant remodelling is currently not known. 
We investigated whether old bones accumulate signals, which 
target the bone for remodeling by osteoclasts. For this purpose, 
human osteoclast precursors were assessed for their ability to 
survive, adhere, differentiate and resorb old versus young bone. 
Methods: Human CD14+ monocytes were isolated by magnetic 
bead sorting. Differentiation of osteoclasts on young (9-months) 
and old (8-years) bone slices was tested, by culturing the mono- 
cytes in the presence of RANKL and M-CSF for 28 days. Differen- 
tiation and resorption were investigated by measuring the TRAcP 
activity, the CTX release in the conditioned medium and by scor- 
ing the pit area. Osteoclast numbers were assessed by counting 
calcitonin receptor positive cells and by measuring TRAcP activ- 
ity in the conditioned medium. Mature osteoclasts were cultured 
on young and old bone for 9 days followed by measurement of 
osteoclast activity and number. Osteoclast adhesion was investi- 
gated by scoring TRAcP positive osteoclasts on bone slices af- 
ter 1,2 and 6 hours. The quantitative differences between young 
and old bones were assessed by measuring the amount of na- 
